Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Financing › Details

eTherapists–Creathor Ventures: investment, 201801 financing round 7-digit € for Humanoo.com from Creathor + DvH Ventures et al

 

Period Period 2018-01-30
Organisations Money taker eTherapists GmbH (Humanoo.com)
  Money source Creathor Venture Management GmbH
  Group Creathor Ventures (Group)
Products Product Humanoo.com
  Product 2 venture capital
Index term Index term eTherapists–SEVERAL: investment, 201801 financing round 7-digit € for Humanoo.com from Creathor + DvH Ventures et al
Person Person Weiss, Christian (Creathor Ventures 201707 Partner)
     

Creathor Venture Management GmbH. (1/30/18). "Press Release: Creathor Invests in E-Health Platform »Humanoo«". Berlin & Bad Homburg v.d.H..

Creathor Ventures, together with Dieter von Holtzbrinck Ventures (DvH Ventures), Rheingau Founders, Rocket Internet and other investors, invests a significant seven-digit amount in HUMANOO, the Berlin-based provider of a digital health companion for employees and insured persons. HUMANOO intends to use the cash infusion to further expand the platform and advance cooperation with health insurance companies and insurers.

HUMANOO’s holistic approach combines fitness, physiotherapy, yoga, wellbeing and nutrition. The HUMANOO app offers users individually tailored exercises, daily workouts and weekly plans, leading them to a self-set goal. All suggestions are based on the focus, fitness level and personal preferences of the user. They are continuously optimized based on the user’s feedback. Personal and company-wide challenges keep engagement rates high. A unique feature of HUMANOO is the direct bonification of healthy user behaviour. Based on the HUMANOO Score, users can receive a bonus payment from the employer for their activities or a premium reduction by health insurance companies and insurers.

“On average, a German employee is absent 21 days a year. If we add the unproductive days that employees appear in the office despite being ill, each company loses an average of EUR 4,600 per employee every year,” explains Philip Pogoretschnik, founder and CEO of HUMANOO. “Most of these sick days are relatively easy to avoid. With HUMANOO we help companies to keep their workforce physically and mentally healthy. In addition to corporate health management, we offer users a holistic platform that combines all content under one roof and rewards health activities and interaction.”

Dr. Christian Weiss, Partner at Creathor Ventures, adds: “Many companies have now realised that healthy employees pay off. However, the offerings available to date are often not scalable across all areas of the company and hardly permit any impact measurement. HUMANOO closes this gap with its digital health platform, which makes it possible for the first time to offer tailor-made solutions for every user.”

In addition, companies and insurance companies can expand their understanding of the wellbeing and health of their employees and insured persons by means of comprehensive reports from HUMANOOO. In this way, the needs of employees and policyholders can be identified and catered for at an early stage. Moreover, a cooperation with HUMANOO contributes to strengthening the employer brand. Leading companies such as Deutsche Bank, P&G, Media Saturn and insurance companies such as Gothaer have already recognized these advantages and are among Humanoo’s satisfied customers.


Logos and photos of Humanoo can be downloaded under the following link: https://www.humanoo.com/en/press/


About Creathor Ventures

Creathor Ventures invests in technology-oriented, fast-growing companies in all stages of their development, especially in the fields of Specialized Artificial Intelligence, Advanced Industry Tech and Enabling Platforms. The regional focus is on Germany, Switzerland, Austria, France and the Nordics. From its offices in Bad Homburg (Frankfurt) and Zurich, the team of 17 staff actively support more than 30 ICT and life science companies in development, growth and internationalization. Creathor Ventures’ management team consists of the Managing Partners Dr Gert Köhler, Karlheinz Schmelig and Cédric Köhler, and the Partners Christian Leikert, Dr Christian Weiss and Christian Weniger. The team has been investing successfully in start-ups for over 30 years and has conducted more than 20 international IPOs during that time. Creathor Ventures currently manages funds of more than EUR 220 million. As the largest investor in its funds, the management underlines its entrepreneurial orientation. For further information visit: www.creathor.com


About Humanoo

HUMANOO was founded in January 2016 by Philip Pogoretschnik and the Berlin-based co-founder Rheingau Founders. In addition to Pogoretschnik, the management team includes Alexander Thieme (formerly Associate with Oliver Wyman) as COO, Christoph Klärner (formerly Head of Technology & Operations at Quaid Media) as CPO, and Thomas Armbruster (formerly CFO at netbooster) as CFO from February on (with completion of this financing round). Since its foundation in 2016, HUMANOO has been able to inspire renowned corporate clients such as Deutsche Bank, P&G, Media Saturn and insurance companies such as Gothaer and the Swiss Mobiliar for its platform. Further information is available at: www.humanoo.com

   
Record changed: 2019-07-13

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for eTherapists GmbH (Humanoo.com)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top